Cervical Adenosquamous Cell Carcinoma Withdrawn Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03834571Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenTreatment